26 June 2018 (Tuesday) - Lymphoma in Myelofibrosis?

The British Society of Haematology sent out an email telling me of an article outlining a possible increase in lymphoma risk for people taking Janus kinase (JAK) inhibitors to treat myelofibrosis.


Something to bear in mind when looking down the microscope at all those already odd-looking cells…

No comments:

Post a comment